Sorry, you need to enable JavaScript to visit this website.
DeliverinG THE LATEST
GREENSTONE News Archive

Get up-to-date product and event news, including information on our generic products.

GREENSTONE LLC ADDS TO ITS GENERIC PORTFOLIO Authorized Generic of VIAGRA® (sildenafil citrate) Tablets

PEAPACK, NJ, July 2017—VIAGRA® (sildenafil citrate) is losing its exclusivity in December 2017,† and GREENSTONE LLC will be there on Day One. Greenstone’s sildenafil citrate is the authorized generic of, and equivalent to the innovator’s product VIAGRA® (sildenafil citrate). GREENSTONE is offering the same medicine in a white tablet.

GREENSTONE’s sildenafil citrate will be offered and available in strengths of 25 mg; 50 mg; and 100 mg.

Read more »

Notification of Product Theft

May 18, 2011 — Pfizer and its Greenstone subsidiary are working with the U.S. Food and Drug Administration, Office of Criminal Investigations (OCI), and other law enforcement officials to recover several different Greenstone products that were stolen on May 14, 2011 while being delivered from Pfizer’s Memphis facility to a customer in the Northeast. The products stolen are listed below. In every instance these products represent a small portion of each product lot.

Read more »

Greenstone Announces Voluntary Nationwide Recall of Citalopram and Finasteride Due to Possible Mislabeling

PEAPACK, N.J., March 26, 2011 — Greenstone LLC announced today that it is voluntarily conducting a recall, to the patient level, of medicines with lot number FI0510058-A on the label. This includes Citalopram 10mg Tablets [100-count bottle] and Finasteride 5mg Tablets [90-count bottle], both distributed in the U.S. market. The recall is due to the possibility that incorrect labels have been placed on the bottles by a third-party manufacturer. This is the only lot number being recalled and no other lots or markets are believed to be impacted.

Read more »